¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"effective mass"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • effective quantum number
    À¯È¿¾çÀÚ¼ö
  • effective renal blood flow
    À¯È¿ÄáÆÏÇ÷·ù·®, À¯È¿½ÅÀåÇ÷·ù·®
  • effective renal plasma flow
    À¯È¿ÄáÆÏÇ÷ÀåÀ¯·®, À¯È¿½ÅÀåÇ÷ÀåÀ¯·®
  • effective temperature chart
    °¨°¢¿ÂµµÇ¥
  • effective temperature index
    À¯È¿¿ÂµµÁö¼ö
  • individual effective dose
    °³ÀÎÀ¯È¿¿ë·®
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • mean effective dose
    Æò±ÕÀ¯È¿¼±·®
  • median effective dose
    1. Áß°£À¯È¿¿ë·® 2. Áß°£À¯È¿¼±·®
  • atomic mass
    ¿øÀÚÁú·®
  • atomic mass unit
    ¿øÀÚÁú·®´ÜÀ§
  • achromatic mass
    ¹«»öµ¢ÀÌ, ºñ¿°»öµ¢ÀÌ
  • body mass index
    ½Åüºñ¸¸Áö¼ö, ½ÅüÁú·®Áö¼ö
  • cavitated mass
    ¼Óºóµ¢ÀÌ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • effective value
    À¯È¿°ª
  • effective alveolar ventilation
    À¯È¿ÆóÆ÷ȯ±â, À¯È¿ÆóÆ÷ȯ±â·®
  • effective blood volume
    À¯È¿Ç÷¾×·®
  • effective circulating volume
    À¯È¿¼øÈ¯¿ëÀû
  • effective dose equivalent
    À¯È¿¼±·®ÇØ´ç·®
  • effective filtration pressure
    À¯È¿¿©°ú¾Ð
  • effective membrane resistance
    À¯È¿¸·ÀúÇ×
  • effective perceived noise level
    ½ÇÈ¿°¨¼ö¼ÒÀ½¼öÁØ, ½ÇÁ¦°¨°¢¼ÒÀ½
  • effective quantum number
    À¯È¿¾çÀÚ¼ö
  • effective renal blood flow
    À¯È¿ÄáÆÏÇ÷·ù·®
  • effective renal plasma flow
    À¯È¿ÄáÆÏÇ÷Àå·ù·®
  • effective temperature index
    À¯È¿¿ÂµµÁö¼ö
  • achromatic mass
    ¹«»öµ¢ÀÌ
  • atomic mass
    ¿øÀÚÁú·®
  • atomic mass unit
    ¿øÀÚÁú·®´ÜÀ§
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ERPF=£¾effective renal plasma flow
    À¯È¿½ÅÇ÷·ù·®.
  • MED => minimum effective dose
    ÃÖ¼ÒÈ«¹Ý·®
  • MED=> minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • MED=£¾minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • effective dose
    À¯È¿¼±·®
  • effective dose 50%
    50% À¯È¿·®, Áß°£À¯È¿·®.
  • effective dose 50% =ED 50%
    Áß°£À¯È¿·®, 50%À¯È¿·®.
  • effective dose =ED
    À¯È¿·®.
  • effective dose equivalent
    À¯È¿¼±·®´ç·®
  • effective filtration pressure
    À¯È¿¿©°ú¾Ð(êóüùÕëΦäâ).
  • effective half life
    À¯È¿¹Ý°¨±â.
  • effective half-life
    À¯È¿¹Ý°¨±â
  • effective liver blood flow
    À¯È¿°£Ç÷·ù·®(êóüùÊÜúì×µÕá).
  • effective membrane resistance
    À¯È¿¸·ÀúÇ×(¡­Ø¯î½ù÷).
  • effective perceived noise level =EPNDB
    ½ÇÈ¿°¨¼ö¼ÒÀ½(Ëà̷˧ËÛËÛËô)·¹ º§.
  • effective power
    À¯È¿·Â.
  • effective quantum number
    À¯È¿·®ÀÚ¼ö(¡­åÖí­â¦).
  • effective radiation temperature
    °¨°¢º¹»ç¿Âµµ(˧˧ËÓË×Ëí̬).
  • effective renal blood flow
    À¯È¿½ÅÇ÷·ù(·®)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mass action
    Áú·®ÀÛ¿ë(òõÕáíÂéÄ)
  • mass-action ratio
    Áú·®ÀÛ¿ëÀ²(òõÕáíÂéÄëÒ)
  • mass balance equation
    Áú·®±ÕÇü¹æÁ¤½Ä(òõÕáгû¬Û°ïïãÒ)
  • mass chromatogram
    Áú·®(òõÕá) Å©·Î¸¶Åä±×·¥
  • mass fragmentography
    Áú·®(òõÕá) ÇÁ·¡±×¸àÅä±×·¡ÇÇ
  • mass number
    Áú·®¼ö(òõÕáâ¦)
  • mass spectrogram
    Áú·®ºÐ±¤µµ(òõÕáÝÂÎÃÓñ)
  • mass spectrograph
    Áú·®ºÐ±¤±â(òõÕáÝÂÎÃѦ)
  • mass spectrometer
    Áú·®ºÐ±¤°è(òõÕáÝÂÎÃͪ)
  • mass spectrum
    Áú·®(òõÕá) ½ºÆåÆ®·³
  • mass unit
    Áú·®´ÜÀ§(òõÕáÓ¤êÈ)
  • molar mass
    ¸ô Áú·®(òõÕá)
  • molecular mass
    ºÐÀÚÁú·®(ÝÂí­òõÕá)
  • nuclidic mass
    ´©Å¬¶óÀ̵å Áú·®(òõÕá)
  • quadrupole mass spectrometer
    »çÁß±ØÀÚ(ÞÌñìпí­) Áú·®ºÐ±¤°è(òõÕáÝÂÎÃͪ).
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mobile mass radiography stand
    À̵¿Çü Áý´Ü¹æ»ç¼±ÃÔ¿µ´ë
  • polypoid mass
    Æú¸³¾çÁ¾±«
  • sonolucent mass
    ÃÊÀ½ÆÄÅõ°ú¼ºÁ¾±«
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EPBF Effective Pulmonary Blood Flow
ERPF Effective Renal Plasma Flow; À¯È¿½ÅÇ÷·ù·®
Te effective Half-Life
AERPAP antegrade effective refractory period accessory pathway
DEPS distal effective potassium secretion
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ED50 Effective Dose
ED50 Effective Dose 50
EDE Effective Dose Equivalent
EOA Effective Orifice Area
ERPF Effective Renal Plasma Flow
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • amorphous mass deposit
    ¹«Á¤Çü Ä§Âø¹°
  • atomic mass
    ¿øÀÚ Áú·®
  • cavitated mass
    °øµ¿¼º Á¾±«
  • cell mass
    ¿ø±â ¼¼Æ÷±º
  • diffuse gingival mass
    ¹Ì¸¸¼º Ä¡Àº Á¾¾ç
  • echogenic mass
    ¿¡ÄÚ ¹ß»ý Á¾±«
  • electronic mass
    ÀüÀÚ Áú·®
  • mass absorption coefficient
    Áú·® Èí¼ö °è¼ö
  • mass examination
    Áý´Ü °ËÁø, Áý´Ü °ËÁø °Ë»ç
  • mass increase
    ÀÀ¾î¸® Áõ°¡
  • mass lesion
    Á¾±«¼º º´º¯
  • mass miniature radiography
    Áý´Ü Ãà¼Ò ¹æ»ç¼± ÃÔ¿µ¼ú, Áý´Ü °£Á¢ ÃÔ¿µ¼ú
  • mass movement
    Áý´Ü ¿îµ¿
  • mass peristalsis
    Áý´Ü ¿¬µ¿, ´ë·® À̵¿¼º ¿¬µ¿
  • mass radiography apparatus
    Áý´Ü ¹æ»ç¼± ÃÔ¿µ ÀåÄ¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
adrenal mass <radiology> Metastasis, most common (especially lung, melanoma), primary adenocarcinoma, large at diagnosis (greater than 5 cm), usually functional (increased corticosteroids most likely to be Cushing's), rapid growth, benign adrenal adenoma, with or without functional, nonfunctional occurs in 2-8% of population, diff from metastasis: MRI (metastasis bright on T2), biopsy, follow, pheochromocytoma, neuroblastoma, myelolipoma, cyst / pseudocyst see also: adrenal calcification, haemorrhage
(12 Dec 1998)
apperceptive mass The already existing knowledge base in a similar or related area with which the new perceptual material is articulated.
(05 Mar 2000)
atomic mass <chemistry, physics> The mass of an atom relative to other atoms.
The present-day basis of the scale of atomic weights is carbon, the most common isotope of this element has arbitrarily been assigned an atomic weight of 12.
The unit of the scale is 1/12 the weight of the carbon atom or roughly the mass of one proton or one neutron. The atomic weight of any element is approximately equal to the total number of protons and neutrons in is nucleus
(16 Dec 1997)
atomic mass unit <chemistry> One-twelfth the mass of a neutral atom of the most abundant isotope of carbon.
(16 Dec 1997)
bilateral adrenal mass <radiology> Acute granulomatous disease (e.g., TB), metastases (bilateral in 15%), pheochromocytoma (bilateral in 10%), adrenal hyperplasia (adenoma), spontaneous adrenal haemorrhage
(12 Dec 1998)
body mass index One of the anthropometric measures of body mass; it has the highest correlation with skinfold thickness or body density.
(12 Dec 1998)
breast mass <oncology, surgery> A breast lump may be benign or cancerous.
Examples of breast lumps include: breast abscess, fat necrosis, fibroadenoma, fibrocystic breast disease and breast cancer. A breast biopsy is the best way to determine the aetiology of a breast lump. Remember, 80 to 85% of all biopsies are benign.
(27 Sep 1997)
para-sellar mass <radiology> Mnemonic: SATCHMO, S sphenoid sinus tumour, A aneurysm / adenoma of pituitary, T teratoid lesion, C craniopharyngioma, H hypothalamic glioma / histiocytoma, M meningioma / metastasis, O optic glioma less common lesions: germinoma, epidermoid, hamartoma, chordoma, arachnoid cyst
(12 Dec 1998)
mass <chemistry> The quantity of matter in an object.
(09 Jan 1998)
mass-action ratio The ratio of the product of all of the product concentrations divided by the product of all of the reactant concentrations of a particular reaction; when the reaction has been completed (i.e., t = &infin;), then this ratio is equal to the equilibrium constant.
(05 Mar 2000)
mass action theory That large areas of brain tissue function as a whole in learned or intelligent action.
(05 Mar 2000)
mass action transmission <epidemiology> Transmission of infection which occurs at a rate directly proportional to the number or density of both susceptibles and infecteds present.
Some authors reserve the name mass action for transmission processes of the form b X Y/N , which we associate with STD-type transmission, and describe transmission rates of the form b X Y , as pseudo-mass action ; the two are equivalent if the population size is unchanging.
(05 Dec 1998)
mass at base of tongue <radiology> Lingual thyroid, thyroglossal duct cyst, haemangioma, other neoplasm
(12 Dec 1998)
mass attenuation coefficient <physics> The mass attenuation coefficient, u/p, of a material for uncharged ionising particles is the quotient of DN/N by pdl, where DN/N is the fraction of particles that experience interactions in traversing a distance dl in a material of density p.
(16 Dec 1997)
mass behaviour Collective behaviour of an aggregate of individuals giving the appearance of unity of attitude, feeling, and motivation.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • folk mass
    Æ÷Å© ¹Ì»ç(ÀüÅëÀû À½¾Ç´ë½Å Æ÷Å© ¹ÂÁ÷À» °çµéÀÌ´Â ¹Ì»ç)
  • high Mass
    (Ä«Å縯) Àå¾öÇÑ ¹Ì»ç
  • mass
    µ¢¾î¸®;Áý´Ü;´Ù¼ö;´Ù·®(He is a ~ of bruises Àü½Å »óó Åõ¼ºÀÌ´Ù);ŹÝ;Áú·® in the ~ ÅëÆ²¾î;the (great) ~ of ...ÀÇ ´ëºÎºÐ;the ~es ´ëÁß
  • mass
    ¹Ì»ç(Ä«Å縯±³ÀÇ ¼ºÃ¼ ¼º»ç);¹Ì»ç°î High Mass (ºÐÇâ,ÁÖ¾ÇÀÌ ÀÖ´Â) ´ë¹Ì»ç
  • mass
    ÇÑ µ¢¾î¸®·Î ÇÏ´Ù(µÇ´Ù);ÁýÁß½ÃŰ´Ù(ÇÏ´Ù)
  • mass action
    Áú·® ÀÛ¿ë
  • mass behavior
    ´ëÁß Çൿ
  • mass circulation
    (´ë·® ¹ßÇàÇÏ´Â) ÀÏ¹Ý ´ëÁß ÀâÁö
  • mass communication
    ´ëÁß Àü´Þ;¸Å½ºÄ¿¹Â´ÏÄÉÀ̼Ç
  • mass defect
    Áú·® °á¼Õ
  • mass driver
    ¿ìÁÖ ±âÀç ¹ß»ç ÀåÄ¡
  • mass energy
    Áú·® ¿¡³ÊÁö
  • mass game
    Áý´Ü °æ±â
  • mass grave
    °øµ¿ ¹¦Áö (µ¿½Ã¿¡ ¸ÅÀåµÈ ¸¹Àº »ç¶÷µéÀÇ ¹¦Áö)
  • mass leave
    (Àεµ¿¡¼­ Ç×ÀÇÇϱâ À§ÇØ ¸¹Àº Á¾¾÷¿øÀÌ ÇÏ´Â) ÀÏÁ¦ ÈÞ°¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á